Dai-ichi Karkaria to Double Alkoxylation Capacity at Dahej Plant with Rs. 10 Crore Investment
Dai-ichi Karkaria Limited has informed BSE of a planned Alkoxylation capacity expansion at its Dahej Plant, targeting an addition of approximately 5000 MT per annum — equal to its existing capacity — within Financial Year 2026-27. The expansion requires an investment of Rs. 10 crores, to be financed entirely through internal accruals. The move is driven by near-full utilisation of existing capacity, which currently stands at approximately 95%. The disclosure was made pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Dai-ichi Karkaria Limited has formally notified BSE of a capacity expansion at its Dahej Plant, pursuant to Regulation 30(4)(d) read with Para B of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, filed on May 9, 2026, pertains to the expansion of the company's Alkoxylation project and was accompanied by a detailed annexure as required under the applicable SEBI Master Circular.
Alkoxylation Capacity Set to Double at Dahej
The company's existing Alkoxylation capacity at the Dahej Plant stands at approximately 5000 MT per annum, depending on product mix, and is currently operating at approximately 95% utilisation. The proposed expansion will add an equivalent capacity of approximately 5000 MT per annum, effectively doubling the total installed Alkoxylation capacity at the facility. The following table summarises the key details of the expansion as disclosed in the regulatory filing:
| Parameter: | Details |
|---|---|
| Existing Capacity – Alkoxylation: | Approx. 5000 MT per annum (depending on product mix) |
| Existing Capacity Utilisation: | Approx. 95% |
| Additional Capacity – Alkoxylation: | Approx. 5000 MT per annum (depending on product mix) |
| Target Completion Period: | Financial Year 2026-27 |
| Investment Required: | Rs. 10 crores |
| Mode of Financing: | Internal accruals |
Investment and Financing
The total investment required for the capacity addition is Rs. 10 crores, which the company intends to fund entirely through internal accruals. This approach indicates that the expansion will be undertaken without recourse to external debt or equity financing, relying on the company's internally generated resources.
Rationale for Expansion
As stated in the regulatory disclosure, the rationale for the capacity addition is that the current Alkoxylation capacity is fully utilised, and additional capacity expansion will be required to support future growth. The near-complete utilisation rate of approximately 95% underscores the operational basis for the investment decision.
The intimation was signed by Ankit Shah, Company Secretary and Compliance Officer of Dai-ichi Karkaria Limited, and submitted to BSE Limited on May 9, 2026.
Historical Stock Returns for Dai-ichi Karkaria
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.06% | -0.10% | -0.23% | -0.23% | -0.23% | -0.23% |
Which specific customer segments or end-use industries is Dai-ichi Karkaria targeting with the additional 5000 MT of Alkoxylation capacity, and are there any long-term supply agreements already in place?
Given that the expansion is fully funded through internal accruals, what does this imply about Dai-ichi Karkaria's cash flow generation capacity, and could further expansions beyond FY2026-27 be financed similarly?
How does Dai-ichi Karkaria's Dahej Alkoxylation expansion compare to capacity additions being undertaken by competitors in the specialty surfactants and ethoxylation space in India?


































